Synlab tops Sdax after DB upgrades to 'Buy'

Synlab AG

31/07/2023 13:10

** Synlab  SYAB.DE  shares rise 3.2%, after rising as much
as 6.4%, after Deutsche Bank upgraded the medical diagnostics
company to "Buy" from "Hold"
    ** DB said an agreement signed last Friday between the
French Ministry of Health and four biologists unions is good
news for Synlab
    ** DB says the deal sets "a new growth ceiling for the
remuneration of laboratories over the next three years" 
    ** "The agreement does not only provide more visibility on
reimbursement in France for Synlab going forward, the outcome is
also significantly better than previously feared", the brokerage
said
    ** France accounts for about 20% of Synlab's sales and more
than 20% of its earnings, according to DB
    ** Synlab is on top of the German small cap index  .SDAXI  
    

 (Reporting by Louis van Boxel-Woolf)
 ((louis.vanboxel-woolf@thomsonreuters.com))